/ /

Cheryl Guttman Krader
Discordance seen with reporting of food oxalate values
A study evaluating the oxalate content of foods as reported by two reputable sources shows discordance.
Stone retrieval device shows high versatility, efficacy
Results from bench studies favor a new open-faced stone retrieval device (Dakota, Boston Scientific) for having greater versatility, efficacy, and durability compared with a competing product, and the in vitro performance of the new instrument is consistent with early clinical experience, says Roger L. Sur, MD.
Endometriosis may be linked to heart disease
The finding of increased risk was robust across multiple endpoints and found to be highest among young women.
Screening for endometriosis risk in adolescents
A questionnaire looks for presence of symptoms that tend to begin in adolescence.
Novel immunomodulators expected to usher in new therapeutic era
A number of systemic and topical treatments for atopic dermatitis are being developed that feature novel mechanisms of action targeting the inflammatory axes involved in the disease.
Pearls to optimize safety, success with biologics
One dermatologist describes his considerations for choosing a biologic to treat a patient with moderate-to-severe psoriasis, baseline assessments, and follow-up approach.
Approval of a new class of implants tops cataract surgery news
Cataract surgeons in the United States have long been envious of the IOL options available to their international colleagues. Finally, in 2016, American ophthalmologists gained access to some novel IOLs such as the Tecnis Symfony Extended Range of Vision IOL and the Tecnis Symfony Toric IOL (Abbott) that were approved by the FDA. According to leading cataract surgeons who spoke to Ophthalmology Times, these simultaneous approvals rank as the biggest cataract surgery news story of the year.
Cataract surgery 2016: News from the pharmaceutical front
A review of some of the most significant advances in medications for cataract surgery during the past year revealed a mix of the expected with a few surprises.
Year in review: Cataract surgery
Looking back over the past year and into the near future, Eric D. Donnenfeld, MD, Robert H. Osher, MD, and Mark Packer, MD, spoke to Ophthalmology Times about developments in diagnostic products and other tools used in cataract surgery. In addition, they discussed combination microinvasive glaucoma surgery (MIGS) and office-based surgery as new trends.
Choosing the right treatment for proliferative diabetic retinopathy
Choosing the right treatment for proliferative diabetic retinopathy
Retina specialists who are Diabetic Retinopathy Clinical Research Network investigators offer views on whether laser panretinal photocoagulation or anti-VEGF therapy deserves consideration as first-line treatment for proliferative diabetic retinopathy.